• Introduced
    Jan 22, 2026
  • Passed House
    Mar 04, 2026
  • Passed Senate
  • Became Law
HB 417
Maryland House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Last Action See all actions
Senate • Apr 13, 2026: Favorable Report by Finance

Summary

Comments on HB 417

Tweets

Whip Lists

Sponsors
Actions
  • Apr 13, 2026 | Senate
    • Favorable Report by Finance
  • Mar 05, 2026 | Senate
    • Referred Finance
  • Mar 04, 2026 | House
    • Third Reading Passed (127-0)
  • Mar 03, 2026 | House
    • Favorable with Amendments Report by Health
    • Favorable with Amendments {953328/1 Adopted
    • Second Reading Passed with Amendments
  • Feb 10, 2026 | House
    • Hearing canceled
    • Hearing 2/10 at 2:30 p.m.
  • Jan 22, 2026 | House
    • First Reading Health
    • Hearing 2/10 at 2:00 p.m.